HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Viale Selected Research

Carcinoma (Carcinomatosis)

1/2018The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.
11/2017Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
9/2015Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
11/2014Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.
4/2013Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
6/2011Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
10/2010Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
2/2008The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
10/2006A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
4/2006Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Viale Research Topics

Disease

223Breast Neoplasms (Breast Cancer)
02/2024 - 04/2002
209Neoplasms (Cancer)
04/2024 - 04/2002
28Neoplasm Metastasis (Metastasis)
11/2022 - 02/2005
19Carcinoma (Carcinomatosis)
01/2018 - 05/2002
16Triple Negative Breast Neoplasms
12/2023 - 09/2008
12Noninfiltrating Intraductal Carcinoma (DCIS)
04/2024 - 03/2003
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 12/2004
8Pathologic Complete Response
02/2024 - 08/2014
8Melanoma (Melanoma, Malignant)
02/2023 - 10/2009
6Lung Neoplasms (Lung Cancer)
01/2019 - 06/2004
5Disease Progression
06/2021 - 03/2004
5Ductal Carcinoma
09/2015 - 07/2009
5Adenocarcinoma
05/2012 - 10/2005
5Small Cell Carcinoma
04/2011 - 11/2003
5Carcinoid Tumor (Carcinoid)
10/2010 - 11/2003
4Residual Neoplasm
02/2024 - 01/2010
4Carcinogenesis
01/2020 - 10/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 10/2002
4Lymphatic Metastasis
08/2014 - 11/2003
3Colonic Neoplasms (Colon Cancer)
01/2023 - 01/2016
3Adenocarcinoma of Lung
01/2021 - 03/2014
3Hypertension (High Blood Pressure)
01/2018 - 03/2009
3Ovarian Neoplasms (Ovarian Cancer)
09/2016 - 10/2006
3Lobular Carcinoma
09/2015 - 10/2009
3Lymphoma (Lymphomas)
10/2011 - 08/2003
3Sarcoma (Soft Tissue Sarcoma)
04/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

62Estrogen ReceptorsIBA
11/2023 - 04/2002
60Hormones (Hormone)IBA
04/2024 - 05/2003
40Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2002
37Progesterone Receptors (Progesterone Receptor)IBA
01/2023 - 05/2002
33human ERBB2 proteinIBA
11/2023 - 12/2005
29Proteins (Proteins, Gene)FDA Link
02/2024 - 04/2003
28Trastuzumab (Herceptin)FDA Link
09/2022 - 07/2008
26TamoxifenFDA LinkGeneric
06/2023 - 06/2003
24Phenobarbital (Luminal)FDA Link
02/2024 - 12/2010
20Estrogens (Estrogen)FDA Link
01/2022 - 09/2004
20Letrozole (Femara)FDA LinkGeneric
01/2021 - 09/2007
18ErbB Receptors (EGF Receptor)IBA
06/2023 - 12/2004
15ParaffinIBA
12/2023 - 07/2012
14Formaldehyde (Formol)FDA Link
12/2023 - 07/2012
13Fluorouracil (Carac)FDA LinkGeneric
08/2015 - 04/2003
11DNA (Deoxyribonucleic Acid)IBA
01/2023 - 06/2010
10RNA (Ribonucleic Acid)IBA
04/2024 - 02/2010
10Messenger RNA (mRNA)IBA
02/2024 - 10/2002
10Cisplatin (Platino)FDA LinkGeneric
08/2015 - 11/2006
9pertuzumabIBA
02/2024 - 07/2017
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023 - 04/2003
8SteroidsIBA
01/2024 - 10/2004
8Aromatase InhibitorsIBA
06/2023 - 07/2014
7exemestane (Aromasin)FDA Link
01/2024 - 07/2014
7Methotrexate (Mexate)FDA LinkGeneric
12/2023 - 04/2003
7AnthracyclinesIBA
12/2021 - 05/2008
7ProgesteroneFDA LinkGeneric
08/2015 - 07/2006
6AntibodiesIBA
02/2024 - 09/2002
6Immune Checkpoint InhibitorsIBA
09/2023 - 10/2016
6Cadherins (E-Cadherin)IBA
01/2020 - 11/2003
6Monoclonal AntibodiesIBA
01/2018 - 11/2003
6fascinIBA
04/2007 - 05/2003
5B7-H1 AntigenIBA
01/2022 - 12/2017
5Docetaxel (Taxotere)FDA Link
10/2020 - 02/2010
5Lapatinib (GW572016)FDA Link
08/2019 - 10/2008
5Cyclin D1IBA
01/2018 - 01/2005
5Epirubicin (Ellence)FDA LinkGeneric
08/2015 - 11/2006
5Vinorelbine (Navelbine)FDA LinkGeneric
06/2015 - 07/2008
4Ado-Trastuzumab EmtansineIBA
02/2024 - 10/2021
4Immunoconjugates (Immunoconjugate)IBA
01/2023 - 09/2022
4liposomal doxorubicin (Doxil)FDA Link
12/2021 - 12/2010
4Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 09/2008
4Capecitabine (Xeloda)FDA Link
10/2020 - 12/2008
4Protein Isoforms (Isoforms)IBA
08/2015 - 07/2005
4Cyclin D3IBA
01/2005 - 08/2003
3Estradiol (Delestrogen)FDA LinkGeneric
01/2024 - 10/2015
3Phosphotransferases (Kinase)IBA
06/2023 - 08/2006
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2022 - 06/2004
3130-nm albumin-bound paclitaxelIBA
01/2022 - 01/2020
3atezolizumabIBA
01/2022 - 01/2020
3MicroRNAs (MicroRNA)IBA
06/2021 - 02/2015
3AndrogensIBA
06/2021 - 07/2006
3taxaneIBA
01/2020 - 03/2009
3Triptorelin Pamoate (Trelstar)FDA Link
10/2019 - 04/2010
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2019 - 02/2007
3Hematoxylin (Haematoxylon)IBA
09/2017 - 02/2005
3Eosine Yellowish-(YS) (Eosin)IBA
09/2017 - 02/2005
3Ki-67 Antigen (Ki 67 Antigen)IBA
02/2016 - 09/2003
3Bevacizumab (Avastin)FDA Link
06/2015 - 03/2009
3Alkylating AgentsIBA
08/2014 - 06/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2013 - 12/2010
3VimentinIBA
06/2011 - 09/2003
3SynaptophysinIBA
04/2011 - 05/2003

Therapy/Procedure

121Therapeutics
02/2024 - 04/2002
61Drug Therapy (Chemotherapy)
12/2023 - 04/2003
19Neoadjuvant Therapy
11/2022 - 11/2004
18Adjuvant Chemotherapy
01/2023 - 04/2003
12Immunotherapy
09/2023 - 11/2017
9Segmental Mastectomy (Lumpectomy)
01/2021 - 03/2004
9Radiotherapy
01/2021 - 03/2004
7Lymph Node Excision (Lymph Node Dissection)
10/2021 - 01/2005
7Mastectomy (Mammectomy)
01/2021 - 03/2003
4Aftercare (After-Treatment)
09/2015 - 06/2003
3Operative Surgical Procedures
10/2015 - 02/2004